Seven IPOs debuted in the US this past week, raising a combined $1.8 billion. Six companies submitted initial filings this ...

It said it will report third-quarter earnings Nov. 7. In the second quarter, Rivian reported a net loss of $1.5 billion, 21 ...

He pointed to the nearly 1,200 medicines in development – including 62 for heart disease, 99 for breast cancer (an all-time ...

Iovance's recent approval and commercial launch of Amtagvi demonstrates strong potential for long-term growth in the oncology ...

Bank of America Securities analyst Sachin Jain has reiterated their bullish stance on AZN stock, giving a Buy rating on September 30. Sachin ...

Dabur is addressing distributor inventory issues in general trade, which may temporarily hurt sales but is essential for ...

Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Aquestive Therapeutics (AQST – Research Report). The ...

Dubai property market will see a strong pipeline of new project launches as nearly 200 additional projects are in the ...